This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2012 Nov 9;1(5):136-138.

doi: 10.1002/cld.97. eCollection 2012 Nov.

Drugs used in therapy of portal hypertension

Dhiraj Tripathi¹

Affiliations

PMID: 31186872
PMCID: PMC6499293
DOI: 10.1002/cld.97

Review

Drugs used in therapy of portal hypertension

Dhiraj Tripathi. Clin Liver Dis (Hoboken). 2012.

. 2012 Nov 9;1(5):136-138.

doi: 10.1002/cld.97. eCollection 2012 Nov.

Author

Dhiraj Tripathi¹

Affiliation

¹ Liver Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.

PMID: 31186872
PMCID: PMC6499293
DOI: 10.1002/cld.97

No abstract available

PubMed Disclaimer

Figures

Figure 1
Hemodynamic effects of terlipressin and octreotide.

See this image and copyright information in PMC

Similar articles

Pathophysiology and a Rational Basis of Therapy.
Gracia-Sancho J, Maeso-Díaz R, Bosch J. Gracia-Sancho J, et al. Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159267
Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.
Garbuzenko DV. Garbuzenko DV. World J Gastroenterol. 2015 May 28;21(20):6117-26. doi: 10.3748/wjg.v21.i20.6117. World J Gastroenterol. 2015. PMID: 26034348 Free PMC article. Review.
[Pharmacological therapy of portal hypertension--focused on Korean data].
Baik SK. Baik SK. Korean J Gastroenterol. 2005 Jun;45(6):381-6. Korean J Gastroenterol. 2005. PMID: 15973071 Korean.
Advances in the treatment of portal hypertension in cirrhosis.
Kimer N, Wiese S, Mo S, Møller S, Bendtsen F. Kimer N, et al. Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):961-9. doi: 10.1586/17474124.2016.1166952. Epub 2016 Mar 28. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26982499 Review.
Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
Ribas J, Angrill J, Barberà JA, García-Pagán JC, Roca J, Bosch J, Rodriguez-Roisin R. Ribas J, et al. Eur Respir J. 1999 Jan;13(1):210-2. doi: 10.1034/j.1399-3003.1999.13a38.x. Eur Respir J. 1999. PMID: 10836350

See all similar articles

Cited by

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.
Kreisel W, Schaffner D, Lazaro A, Trebicka J, Merfort I, Schmitt-Graeff A, Deibert P. Kreisel W, et al. Int J Mol Sci. 2020 Aug 28;21(17):6223. doi: 10.3390/ijms21176223. Int J Mol Sci. 2020. PMID: 32872119 Free PMC article. Review.
Use of Non-Selective Beta-Blocker for Refractory Stomal Variceal Hemorrhage.
Mu X, Winsor W, Trahey J. Mu X, et al. Case Rep Gastroenterol. 2021 Jan 26;15(1):87-91. doi: 10.1159/000510921. eCollection 2021 Jan-Apr. Case Rep Gastroenterol. 2021. PMID: 33613168 Free PMC article.
Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation.
Cheng HY, Lin HC, Lin HL, Uang YS, Keller JJ, Wang LH. Cheng HY, et al. Front Pharmacol. 2022 Jan 7;12:805318. doi: 10.3389/fphar.2021.805318. eCollection 2021. Front Pharmacol. 2022. PMID: 35069216 Free PMC article.
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.
Reiberger T, Berzigotti A, Trebicka J, Ertle J, Gashaw I, Swallow R, Tomisser A. Reiberger T, et al. Trials. 2023 Apr 24;24(1):293. doi: 10.1186/s13063-023-07291-3. Trials. 2023. PMID: 37095557 Free PMC article. Clinical Trial.

References

1. Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982;2:523–527. - PubMed
1. Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but ‘splanchnic steal’. QJM 2002;95:827–830. - PubMed
1. Garcia‐Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922–938. - PubMed
1. Tripathi D, Hayes PC. Review article: a drug therapy for the prevention of variceal haemorrhage. Aliment Pharmacol Ther 2001;15:291–310. - PubMed
1. Tripathi D, Hayes PC. The role of carvedilol in the management of portal hypertension. Eur J Gastroenterol Hepatol 2010;8:905–911. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources